DSM-Firmenich stock gains new bio-based resin capacity in France

DSM-Firmenich announced on Monday, November 9, 2026, that production is ramping up at a new hydrogenated bio-based resins unit in Vielle-Saint-Girons, southwestern France. The company said the facility was commissioned during the first half of 2026 and now manufactures resins and derivatives for industrial applications.

Capacity targets industrial demand

In a company announcement, DSM-Firmenich said the unit belongs to its DRT Industry Ingredients business. Its products target adhesives, coatings, paints and chewing gum, with applications including electronics, automotive products and road signage.

The plant will produce the hydrogenated rosin resins DRT Foral and Staybelite. DSM-Firmenich said the products are made from pine-based rosin and are designed to combine low color with stability under significant temperature changes and demanding climatic conditions.

Global reach for specialty ingredients

The additional capacity is intended to support customers in Europe, North America and Asia. The company said the fully automated site strengthens its capabilities in high-end rosin resins and supports the commercialization of products for industrial markets.

More than 50 companies contributed to construction, including 90 percent local firms, alongside 120 equipment suppliers. The site carries ISO 50001 and FSSC 22000 certifications, while DSM-Firmenich said more than 90 percent of its co-products are valorized.

Swiss equities remain part of the wider market setting, with the SMI market environment providing the relevant regional reference.

For investors, the expansion gives the Ingredients, Perfumery & Beauty business additional industrial capacity while adding a tangible production milestone to the companys portfolio reshaping. More news and analyses on DSM-Firmenich stock are available in the company topic.